BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17031553)

  • 1. Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme.
    Turner CD; Chi S; Marcus KJ; MacDonald T; Packer RJ; Poussaint TY; Vajapeyam S; Ullrich N; Goumnerova LC; Scott RM; Briody C; Chordas C; Zimmerman MA; Kieran MW
    J Neurooncol; 2007 Mar; 82(1):95-101. PubMed ID: 17031553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas.
    Fine HA; Figg WD; Jaeckle K; Wen PY; Kyritsis AP; Loeffler JS; Levin VA; Black PM; Kaplan R; Pluda JM; Yung WK
    J Clin Oncol; 2000 Feb; 18(4):708-15. PubMed ID: 10673511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas.
    Packer RJ; Krailo M; Mehta M; Warren K; Allen J; Jakacki R; Villablanca JG; Chiba A; Reaman G
    Cancer; 2005 Nov; 104(9):1968-74. PubMed ID: 16177987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of metronomic chemotherapy with thalidomide, carboplatin-vincristine-fluvastatin in the treatment of brain stem tumors in children.
    López-Aguilar E; Sepúlveda-Vildósola AC; Betanzos-Cabrera Y; Rocha-Moreno YG; Gascón-Lastiri G; Rivera-Márquez H; Wanzke-del-Angel V; Cerecedo-Díaz F; de la Cruz-Yañez H
    Arch Med Res; 2008 Oct; 39(7):655-62. PubMed ID: 18760193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme.
    Chang SM; Lamborn KR; Malec M; Larson D; Wara W; Sneed P; Rabbitt J; Page M; Nicholas MK; Prados MD
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):353-7. PubMed ID: 15380566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study.
    Korones DN; Fisher PG; Kretschmar C; Zhou T; Chen Z; Kepner J; Freeman C
    Pediatr Blood Cancer; 2008 Feb; 50(2):227-30. PubMed ID: 17278121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
    Marcus KJ; Dutton SC; Barnes P; Coleman CN; Pomeroy SL; Goumnerova L; Billett AL; Kieran M; Tarbell NJ
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1182-5. PubMed ID: 12654425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma.
    Haas-Kogan DA; Banerjee A; Kocak M; Prados MD; Geyer JR; Fouladi M; McKnight T; Poussaint TY; Broniscer A; Blaney SM; Boyett JM; Kun LE
    Neuro Oncol; 2008 Jun; 10(3):341-7. PubMed ID: 18417739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of temozolomide plus thalidomide during and after radiation therapy for pediatric diffuse pontine gliomas: preliminary results of the Korean Society for Pediatric Neuro-Oncology study.
    Kim CY; Kim SK; Phi JH; Lee MM; Kim IA; Kim IH; Wang KC; Jung HL; Lee MJ; Cho BK
    J Neurooncol; 2010 Nov; 100(2):193-8. PubMed ID: 20309719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma.
    Sharp JR; Bouffet E; Stempak D; Gammon J; Stephens D; Johnston DL; Eisenstat D; Hukin J; Samson Y; Bartels U; Tabori U; Huang A; Baruchel S
    Eur J Cancer; 2010 Dec; 46(18):3271-9. PubMed ID: 20656474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas.
    Hall WA; Doolittle ND; Daman M; Bruns PK; Muldoon L; Fortin D; Neuwelt EA
    J Neurooncol; 2006 May; 77(3):279-84. PubMed ID: 16314949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme.
    Groves MD; Puduvalli VK; Chang SM; Conrad CA; Gilbert MR; Tremont-Lukats IW; Liu TJ; Peterson P; Schiff D; Cloughesy TF; Wen PY; Greenberg H; Abrey LE; DeAngelis LM; Hess KR; Lamborn KR; Prados MD; Yung WK
    J Neurooncol; 2007 Feb; 81(3):271-7. PubMed ID: 17031561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of a Single Angiogenesis Inhibitor in the Treatment of Recurrent Glioblastoma Multiforme: A Meta-Analysis and Systematic Review.
    Wang Y; Xing D; Zhao M; Wang J; Yang Y
    PLoS One; 2016; 11(3):e0152170. PubMed ID: 27007828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide as an anti-angiogenic agent in relapsed gliomas.
    Short SC; Traish D; Dowe A; Hines F; Gore M; Brada M
    J Neurooncol; 2001 Jan; 51(1):41-5. PubMed ID: 11349879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
    Kesari S; Schiff D; Doherty L; Gigas DC; Batchelor TT; Muzikansky A; O'Neill A; Drappatz J; Chen-Plotkin AS; Ramakrishna N; Weiss SE; Levy B; Bradshaw J; Kracher J; Laforme A; Black PM; Folkman J; Kieran M; Wen PY
    Neuro Oncol; 2007 Jul; 9(3):354-63. PubMed ID: 17452651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium.
    Pollack IF; Stewart CF; Kocak M; Poussaint TY; Broniscer A; Banerjee A; Douglas JG; Kun LE; Boyett JM; Geyer JR
    Neuro Oncol; 2011 Mar; 13(3):290-7. PubMed ID: 21292687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806).
    Alexander BM; Wang M; Yung WK; Fine HA; Donahue BA; Tremont IW; Richards RS; Kerlin KJ; Hartford AC; Curran WJ; Mehta MP
    J Neurooncol; 2013 Jan; 111(1):33-9. PubMed ID: 23086432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. Brainstem Glioma Cooperative Group.
    Broniscer A; Leite CC; Lanchote VL; Machado TM; Cristófani LM
    J Clin Oncol; 2000 Mar; 18(6):1246-53. PubMed ID: 10715294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.